Advertisement

HIV und Aids pp 206-278 | Cite as

Neurologische Manifestationen der HIV-1-Infektion/Aids

  • I. W. Husstedt
  • S. Evers
  • F. Stögbauer
  • G. Schuierer

Zusammenfassung

Derzeit gibt es nach Angaben der WHO ca. 20 Mio. HIV-1-Infizierte, vermutlich wird bereits im Jahr 2000 die 4o-Mio.-Grenze überschritten sein. Bei 70 % aller HIV-1-Infizierten wird das Nervensystem in den Krankheitsprozeß einbezogen. Primäre oder sekundäre Neuromanife-stationen werden von Neuropathologen sogar bei bis zu 90% aller Patienten gefunden. Es besteht eine klare Korrelation zwischen der Progredienz der HIV-1-Infektion und der Zunahme von Neuromani-festationen. Die rasante Zunahme der Überlebensspanne im Aids-Stadium dürfte dazu führen, daß in noch größerem Ausmaß Neuro-manifestationen auftreten, die fachspezifischischer Diagnostik und Therapie bedürfen (Baceliar et al. 1994).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Armstrong D, Gold JWM, Dryjanski J et al. (1985) Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 103: 738–743PubMedGoogle Scholar
  2. Atkinson, JH, Grant I, Kennedy CJ et al. (1988) Prevalence of psychiatric disorders among men infected with Human Immunodeficiency Virus — a controlled study. Arch Gen Psychiat 45: 859–864PubMedCrossRefGoogle Scholar
  3. Baceliar H, Munoz A, Miller EN et al. (1994)Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS cohort study, 1985-1992. Neurology 44: 1892–1900Google Scholar
  4. Behar R, Wiley C, McCutchan JA (1987) Cytomegalovirus polyradiculoneuropathy in Acquired Immuno-Deficiency-Syndrome. Neurology 37: 55–61Google Scholar
  5. Bell JE, Busuttil JW, Ironside JW et al. (1993) Human immunodeficiency virus and the brain: Investigation of virus load and neuropathogenic changes in pre-AIDS subjects. J Infect Dis 168: 818–824PubMedCrossRefGoogle Scholar
  6. Berenguer J, Moreno S, Laguna F et al. (1992) Tuberculous meningitis in patients with the human immunodeficiency virus. N Engl J Med 326: 668–672PubMedCrossRefGoogle Scholar
  7. Berger JR, Flaster M, Schatz N et al. (1993) Cranial neuropathy heralding otherwise occult AIDS-related large cell lymphoma. J Clin Neuro-Ophthalmol 13: 113Google Scholar
  8. Berger JR, Mucke L (1988) Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukencephalopathy. Neurology 38: 1060–1065PubMedGoogle Scholar
  9. Bessen LJ, Greene JB, Louie E et al. (1988) Severe polymyositis-like syndrome associated with zidovudine-therapy of AIDS and ARC. N Engl J Med 318: 708PubMedGoogle Scholar
  10. Brandon WR, Boulos LM, Morse A (1993) Determining the prevalence of neurosyphilis in a cohort co-infected with HIV. Int J St AIDS 4: 99–101Google Scholar
  11. Burger DM, Kraayeveld CL, Meenhorst PL et al. (1993) Penetration of zidovudine into the cerebrospinal fluid (CSF) of patients with HIV. AIDS 7: 1581–1587PubMedCrossRefGoogle Scholar
  12. Carne CA, Stibe C, Bronkhurst A et al. (1989) Subclinical neurological and neurop-sychological effect of infection with HIV. Genitourin Med 65: 151–156PubMedGoogle Scholar
  13. Centers for Disease Control (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41(RR-17): 1–19Google Scholar
  14. Chavanet PY, Giroud M, Lancon JP et al. (1988) Altered peripheral nerve conduction in HIV-patients. Canter Detect Prev 12: 249–255Google Scholar
  15. Chuck SL, Sande MA (1989) Infections with crytococcus neoformans in acquired immunodeficiency syndrome. N Engl J Med 321: 794–799PubMedCrossRefGoogle Scholar
  16. Clark SJ, Saag MS, Decker WD et al. (1991) High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1-infection. N Engl J Med 324:954PubMedCrossRefGoogle Scholar
  17. Cohen BA (1996) Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS. Neurology 46: 444–449PubMedGoogle Scholar
  18. Cohen BA, McArthur JC, Grohmann S et al. (1993) Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS. Neurology 43: 493–499PubMedGoogle Scholar
  19. Cornblath DR, McArthur J, Kennedy PGE et al. (1987) Inflammatory demyelinating peripheral neuropathies associated with HTLV-II infection. Ann Neurol 21: 32–40PubMedCrossRefGoogle Scholar
  20. Cornblath DR, Chaudhry V, Griftin JW (1991) Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Ann Neurol 30: 104–106PubMedCrossRefGoogle Scholar
  21. Dal Pan GJ, McArthur JC, Aylward E et al. (1992) Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology 42: 2125–2130Google Scholar
  22. Davis LE, Hjelle BL, Miller VE et al. (1992) Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42: 1736–1739PubMedGoogle Scholar
  23. De Luca A, Antinori A, Cingolani A et al. (1995) Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 90: 844–849PubMedCrossRefGoogle Scholar
  24. Denning WP, Anderson J, Rudge P, Smith H (1987) Acute myelopathy associated with primary infection with human immunodeficiency virus. BMJ 294: 143–144PubMedCrossRefGoogle Scholar
  25. Dina TS (1991) Primary central nervous system lymphoma versus toxoplasmosis in AIDS. Radiology 179: 823–828PubMedGoogle Scholar
  26. Dowell ME, Ross PG, Musher DM et al. (1992) Response of latent syphilis or neuro-syphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus infection. Am J Med 93: 520–524CrossRefGoogle Scholar
  27. Dube MP, Holtom PD, Larsen RA (1992) Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 93: 520–524PubMedCrossRefGoogle Scholar
  28. Duh EJ, Maury WJ, Folks TM et al. (1989) Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kB sites in the long terminal repeat. Proc Nat Acad Sci USA 86: 5974–5978PubMedCrossRefGoogle Scholar
  29. Dunkle L, Anderson R, McLaren C (1992) Stavudine (d4T) a promising antiretrovi-ral agent. VIII International Conference on AIDS/III STD World Congress (abstr.)Google Scholar
  30. Dunlop O, Bjørklund R, Abelnoor M, Myrvang B (1992) Five different tests of reaction time evaluated in HIV seropositive men. Acta Neurol Scand 88: 344–348CrossRefGoogle Scholar
  31. Dutch TIA Trial Study Group (1991) A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 325: 1261–1266CrossRefGoogle Scholar
  32. Engstrom JW, Lowenstein DH, Bredesen DE (1989) Cerebral infarctions and transient neurological deficits associated with acquired immunodeficiency syndrome. Am J Med 86: 528–532PubMedCrossRefGoogle Scholar
  33. Enting RH, Esselink RA, Portegies P et al. (1994) Lymphomatous meningitis in AIDS-related systemic non-Hodgkin’s lymphoma: a report of eight cases. J Neurol Neurosurg Psychiatry 57: 150–153PubMedCrossRefGoogle Scholar
  34. Evers S, Husstedt IW, Lüttmann S et al. (1996a) Event-related potentials in HIV infection: evidence for impact of antiretroviral treatment. Arch Neurol 53: 715–716PubMedCrossRefGoogle Scholar
  35. Evers S, Lüttmann S, Bauer B et al. (1996b) Changes of migraine features during HIV infection. Neurovirology 2: 36Google Scholar
  36. Faed JM, Day B, Pollock M et al. (1989) High dose intravenous human immunoglo-bulin in chronic inflammatory demyelinating polyneuropathy. Neurology 39: 422–425PubMedGoogle Scholar
  37. Fisher M, Tomlinson DR, Coker RJ et al. (1995) Management of cytomegalovirus infection. Int J St AIDS 6: 313–319Google Scholar
  38. Formenti SC, Gill PS, Lean E et al. (1989) Primary central nervous system lymphoma in AIDS: results of radiation therapy. Cancer 63: 1101PubMedCrossRefGoogle Scholar
  39. Gabuzda DH, Ho DD, de La Monte SM et al. (1986) Immunohistochemical identification of HTLV-II antigen in brains of patients with AIDS. Ann Neurol 20: 289–295PubMedCrossRefGoogle Scholar
  40. Gade W, Ledman DW, Wethington R et al. (1992) Serological responses to various cocccidionides antigen preparations in a new enzyme immunoassay. J Clin Microbiol 39: 1907–1912Google Scholar
  41. Gertner E, Thurn JR, Williams DN et al. (1989) Zidovudine-associated myopathy. Am J Med 86: 814–818PubMedCrossRefGoogle Scholar
  42. Goldstein J (1990) Headache and Acquired Immunodeficiency Syndrome. Neurol Clin 8: 947–960PubMedGoogle Scholar
  43. Goswami KK, Miller RF, Harrison MJ et al. (1991) Expression of HIV-1 in the cere-brospinal fluid detected by the polymerase chain reaction and its correlation with central nervous system disease. AIDS 5: 797–803PubMedCrossRefGoogle Scholar
  44. Grant IH, Gold JMW, Rosenblum M et al. (1990) Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmo-sis in AIDS. AIDS 4: 519–521PubMedCrossRefGoogle Scholar
  45. Gray F, Geny C, Dournon E et al. (1991) Neuropathological ecidence that zidovudi-ne reduces incidence of HIV infection of the brain. Lancet 337: 852–853PubMedCrossRefGoogle Scholar
  46. Griffin DE, McArthur JC, Cornblath DR (1990) Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease. J Neuroimmunol 28: 97–109PubMedCrossRefGoogle Scholar
  47. Grotemeyer KH, Husstedt IW, Bründermann H (1991) Event-related potentials in HIV-infected outpatients. AIDS Res Hum Retrovir 7: 629–635PubMedCrossRefGoogle Scholar
  48. Harrison MJG, Justin C, McArthur JC (1995) AIDS and Neurology. Churchill Livingstone, EdinburghGoogle Scholar
  49. Hicks CB, Benson PM, Lupton G et al. (1987) Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma: a diagnostic dilemma. Ann Intern Med 107: 492–495PubMedGoogle Scholar
  50. Ho DD (1995) Time to hit HIV early and hard. N Engl J Med 333: 450–451PubMedCrossRefGoogle Scholar
  51. Hoffman, JM, Waskin HA, Schifter T et al. (1993) FDG-PET in differentiating lym-phoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 34: 567–575PubMedGoogle Scholar
  52. Holland NR, Power C, Mathews MD et al. (1994) Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology 44: 507–514PubMedGoogle Scholar
  53. Holliman RE (1990) Serological study of the prevalence of toxoplasmosis in asymptomatic patients infected with human immunodeficiency virus. Epidemiol Infect 105: 415–418PubMedCrossRefGoogle Scholar
  54. Holloway RG, Kieburtz KD (1995) Headache and the human immunodeficiency virus type 1 infection. Headache 35: 245–255PubMedCrossRefGoogle Scholar
  55. Holtzman DM, Kaku DA, So YT (1989) New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med 87: 173–177PubMedCrossRefGoogle Scholar
  56. Hook EW (1989) Syphilis and HIV infection. J Infect Dis 160: 530–534PubMedCrossRefGoogle Scholar
  57. Husstedt IW, Grotemeyer KH, Busch H et al. (1993) Progression of distal-symmetric polyneuropathy in HIV infection: a prospective study. AIDS 7: 1069–1073PubMedCrossRefGoogle Scholar
  58. Husstedt IW, Grotemeyer KH, Busch J et al. (1994) Early detection of distal symmetrical polyneuropathy during HIV infection by paired stimulation of sural nerve. Electroenc Clin Neurophys 93: 169–174CrossRefGoogle Scholar
  59. Husstedt IW, Lügering N, Heese C et al. (1995) Polyneuroradikulitis bei HIV-Infektion — Verlauf, differentialdiagnostische und therapeutische Aspekte. MMW 137: 487–490Google Scholar
  60. Husstedt IW, Yilmaz M, Reichelt D et al. (1996) Die autonome Polyneuropathie HIV-Infizierter — ein Vergleich zu Patienten mit Diabetes mellitus und Probanden. In: Jäger (ed) AIDS-Management der Erkrankung: Szenarien zur Verbesserung von Diagnose und Behandlung. Ecomed, Landsberg/LechGoogle Scholar
  61. Husstedt IW, Plettenberg A, Reichelt D et al. (1997) Kasuistiken — Einsatz von Atovaquon in der Behandlung und Prophylaxe der cerebralen und okulären Toxoplasmose bei HIV-infizierten Patienten. DMW (zur Publ. eingereicht)Google Scholar
  62. Irani DN, Cornblath DR, Chaudhry V et al. (1993) Relapse in Guillain-Barré syndrome after treatment with human immune globulin. Neurology43: 872–875Google Scholar
  63. Janssen RS, Cornblath DR, Epstein LG et al. (1991) Nomenclature and research case definitions for neurological manifestations of human immunodeficiency disorder. Ann Neurol 41: 778–785Google Scholar
  64. Jolies S, Kinloch de Loës S, Johnson M A (1996) Primary HIV-1 infection: a new medical emergency? Recognition of this initial illness may permit early diagnosis and treatment. BMJ 312: 1243–1244CrossRefGoogle Scholar
  65. Karahalios D, Breit R, Dal Canto MC et al. (1992) Progressive multifocal leukence-phalopathy in patients with HIV infection: lack of impact of early diagnosis by stereotactic brain biopsy. J Acquired Immunodeficiency Syndromes 5: 1030–1038Google Scholar
  66. Katz DA, Berger JR (1989) Neurosyphilis in acquired immunodeficiency syndrome. Arch Neurol 46: 895–898PubMedCrossRefGoogle Scholar
  67. Kinloch de Loës S, Hirschel BJ, Hoen B et al. (1996) A controlled trial of Zidovudine in primary human immunodeficiency virus infection. N Engl J Med 333: 408–413CrossRefGoogle Scholar
  68. Levy RM, Bredesen DE, Rosenblum ML et al. (1989) Central nervous system disorders in AIDS. Immunol Ser 44: 371–401PubMedGoogle Scholar
  69. Lipton SA (1992) Memantine prevents HIV-coat protein-induced neuronal injury in vitro. Neurology 42: 1403–1405PubMedGoogle Scholar
  70. Lipton RB, Feraru ER, Weiss G et al. (1991) Headache in HIV1-related disorders. Headache 31: 518–522PubMedCrossRefGoogle Scholar
  71. Lüttmann S, Husstedt IW, Lügering N et al. (1997) Cytomegalovirus Encephalo-myelomeningoradiculitis in Acquired Immunodeficiency Syndrome (AIDS). Journal of Infection (im Druck)Google Scholar
  72. McArthur JC (1987) Neurologic manifestations of AIDS. Medicine 66: 407–437PubMedCrossRefGoogle Scholar
  73. McArthur JC, Nance-Sproson TE, Griffin DE et al. (1992) The diagnostic utility of elevation in cerebrospinal fluid ß2 microglobulin in HIV-1 dementia. Neurology 42: 1707–1712PubMedGoogle Scholar
  74. McArthur JC, Hoover DR, Baceliar H et al. (1993), Dementia in AIDS patients: incidence and risk factors. Neurology 43: 2245–2252PubMedGoogle Scholar
  75. Miörner H, Sjöbring U, Nayak P (1995) Tubercle and Lung Disease 76: 381–386PubMedCrossRefGoogle Scholar
  76. Mizusawa H, Hirano A, Llena JF et al. (1988) Cerebrovascular lesions in acquired immune deficiency syndrome (AIDS). Acta Neuropathol 76: 451–457PubMedCrossRefGoogle Scholar
  77. Musher DM (1991) Syphilis, neurosyphilis, penicillin, and AIDS. J Infect Dis 63: 1201–1206CrossRefGoogle Scholar
  78. Naber D (1994) Neuropsychiatrische Störungen bei AIDS. MMW 136: 238–240Google Scholar
  79. Naber D, Perro C, Schick U et al. (1989) Psychiatrische Symptome und neuropsy-chologische Auffälligkeiten bei HIV-Infizierten. Nervenarzt 60: 80–85PubMedGoogle Scholar
  80. Navia BA, Petito CK, Gold JW et al. (1986) Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol 19: 224–238PubMedCrossRefGoogle Scholar
  81. østergaard L, Nielsen AK, Black FT (1993) DNA Amplification on cerebrospinal fluid for diagnosis of cerebral toxoplasmosis among HIV-positive patients with signs or symptoms of neurological disease. Scand J Infect Dis 25: 227–237PubMedCrossRefGoogle Scholar
  82. Perry SW, Jacobsen P (1986) Neuropsychiatric manifestation of AIDS spectrum disorders. Hosp Comm Psychiatr 37: 135–142Google Scholar
  83. Petito CK (1993) Myelopathies. In: Scaravilli F (ed) The neuropathology of HIV infection. Springer, London, pp 187–199Google Scholar
  84. Petito CK, Navia BA, Cho ES et al. (1985) Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with acquired immune deficiency syndrome. N Engl J Med 312: 874–879PubMedCrossRefGoogle Scholar
  85. Portegies P (1994) AIDS dementia complex: A review. J Acq Immune Def Synd 7(Suppl 2): 38–49.Google Scholar
  86. Price RW, Brew BJ (1997) Central and peripheral nervous system complications. In: DeVita VT, Hellman S, Rosenberg SA (eds) AIDS: Biology, diagnosis, treatment and prevention, 4th edn. 331–354Google Scholar
  87. Reiber H (1980) The discrimination between different blood-CSF barrier dysfunctions and inflammtory reactions of the CNS by a recent evaluation graph for the protein profile of cerebrospinal fluid. J Neurol 224: 89–99PubMedCrossRefGoogle Scholar
  88. Ruiz A, Ganz WI, Donovan Post, JM et al. (1994) Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. AJNR 15: 1885–1894PubMedGoogle Scholar
  89. Salim YS, Faber V, Skinhoj P et al. (1989) Plasmaferesebehandling af perifer HIV-neuropati. Ugeskr Laeger 151: 1754–1756PubMedGoogle Scholar
  90. Scaravilli F, Daniel SE, Harcourt-Webster N et al. (1989) Chronic basal meningitis and vasculitis in acquired immunodeficiency syndrome: a possible role for human immunodeficiency virus. Arch Pathol Lab Med 113: 192–195PubMedGoogle Scholar
  91. Schielke E (1993) Die HIV-Enzephalopathie — Klinik, Neuropathologie und Pathogenese. Nervenarzt 64: 83–90PubMedGoogle Scholar
  92. Schmid P, Conrad A, Syndulko K et al. (1994) Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities. J Acq Immune DefSynd 7: 777–778Google Scholar
  93. Simpson DM, Wolfe DE (1991) Neuromuscular complications of HIV infection and its treatment. AIDS 5: 917–926PubMedCrossRefGoogle Scholar
  94. Simpson DM, Citak KA, Godfrey E et al. (1993a) Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished? Neurology 43: 971–976PubMedGoogle Scholar
  95. Simpson D, Goldbold J, Hassett S et al. (1993b) HIV associated myopathy and the effects of zidovudine and prednisone: preliminary results of placebo-controlled trials. Clin Neuropathol 12(Suppl 1): 20–23Google Scholar
  96. Sinclair E, Gray F, Scaravilli F (1992) PCR detection of HIV proviral DNA in the brain of an asymptomatic HIV-positive patient. J Neurol 239: 469–471PubMedCrossRefGoogle Scholar
  97. Singer EJ, Zorilla C, Fahy-Chandon B et al. (1993) Painful syndroms reported by ambulatory HIV-infected men in a longitudinal study. Pain 54: 15–19PubMedCrossRefGoogle Scholar
  98. Singer EJ, Kim J, Fahy-Chandon B et al. (1996) Headache in ambulatory HIV-1-infected men enrolled in a longitudinal study. Neurology 47: 487–494PubMedGoogle Scholar
  99. Snider WD, Simpson DM, Nielsen S et al. (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14: 403–418PubMedCrossRefGoogle Scholar
  100. So T, Holtzman DM, Abrams DI et al. (1988) Peripheral neuropathy associated with acquired immunodeficiency syndrome. Arch Neurol 45: 945–948PubMedCrossRefGoogle Scholar
  101. Soong S-J, Watson NE, Caddell GR et al. (1991) Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: a statistical model and its clinical implications. J Infect Dis 163: 17–22PubMedCrossRefGoogle Scholar
  102. UK-TIA-Study Group (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiat 54: 1044–1054CrossRefGoogle Scholar
  103. Viard J-P, Vittecoq D, Lacroix C et al. (1992) Response of HIV-1-associated polym-yositis to intravenous immunoglobulin (letter). Am J Med 92: 580–581PubMedCrossRefGoogle Scholar
  104. Vollmer-Haase J, Young P, Ringelstein EB (1997) Efficacy of camptothecin in progressive multifocal leucencephalopathy. Lancet 349: 1366PubMedCrossRefGoogle Scholar
  105. Weber T, Turner RT, Frye S et al. (1994) Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 169: 1138–1141PubMedCrossRefGoogle Scholar
  106. Whiteman MLH, Post MJ, Berger JR et al. (1993) Progressive multifocal leukence-phalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathological correlation. Radiology 187: 233–240PubMedGoogle Scholar
  107. Wolcott Deane L, Dilley JW, Mitsuyasu RT (1994) Aids und Psychiatric In: Freed-man AM, Kaplan HI, Sadock BJ et al. (eds) Psychiatrie in Klinik und Praxis, Bd 7: Aids und Psychiatric Thieme, Stuttgart, S 227–258.Google Scholar
  108. Wong MC, Suite NDA, Labar DR (1990) Seizures in human immunodeficiency virus infection. Arch Neurol 47: 640–642PubMedCrossRefGoogle Scholar
  109. Zakowski P, Fliegel S, Berlin GW et al. (1982) Disseminated mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency. JAMA 248: 2980–2982PubMedCrossRefGoogle Scholar
  110. Zunker P, Nabavi DG, Allardt A et al. (1996) HIV-associated stroke: report on two unusual cases. Stroke 27: 1694–1695PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • I. W. Husstedt
  • S. Evers
  • F. Stögbauer
  • G. Schuierer

There are no affiliations available

Personalised recommendations